risks of tirzepatide Mechanisms action, benefits, and of in CVDs Tirzepatide and Cancer Risk in

Researchers say adults over the age of 65 can reduce their risk of type 2 diabetes by taking low-dose aspirin daily, but experts say the risk of bleeding may outweigh that benefit.

While newly approved pharmacotherapies such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) show efficacy, their clinical utility remains constrained by dose-dependent gastrointestinal complications, underscoring the urgent need for safer alternatives

Three large observational studies provide more data

Selecting the right patients for GLP-1 therapy and monitoring them closely is key to ensuring safety and optimizing outcomes

This roundhouse formula targets your stress, supports your mood, and gives you the support you need to feel like yourself again

Root-cause medical weight loss in the Raleigh-Triangle